DK0831938T3 - Radiomærkede peptidsammensætninger til stedspecifik målsögninger - Google Patents

Radiomærkede peptidsammensætninger til stedspecifik målsögninger

Info

Publication number
DK0831938T3
DK0831938T3 DK96922403T DK96922403T DK0831938T3 DK 0831938 T3 DK0831938 T3 DK 0831938T3 DK 96922403 T DK96922403 T DK 96922403T DK 96922403 T DK96922403 T DK 96922403T DK 0831938 T3 DK0831938 T3 DK 0831938T3
Authority
DK
Denmark
Prior art keywords
somatostatin
peptide
radiolabeled peptide
radiolabeled
site
Prior art date
Application number
DK96922403T
Other languages
Danish (da)
English (en)
Inventor
Ananthachari Srinivasan
Joseph E Bugaj
Mary Marmion Dyszlewski
Jack L Erion
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23907713&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0831938(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of DK0831938T3 publication Critical patent/DK0831938T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK96922403T 1995-06-07 1996-06-06 Radiomærkede peptidsammensætninger til stedspecifik målsögninger DK0831938T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/480,373 US5830431A (en) 1995-06-07 1995-06-07 Radiolabeled peptide compositions for site-specific targeting
PCT/US1996/009384 WO1996040291A1 (en) 1995-06-07 1996-06-06 Radiolabeled peptide compositions for site-specific targeting

Publications (1)

Publication Number Publication Date
DK0831938T3 true DK0831938T3 (da) 2008-07-21

Family

ID=23907713

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07019899.9T DK1872800T3 (da) 1995-06-07 1996-06-06 Radiomærkede peptidsammensætninger til stedsspecifik målsøgning
DK96922403T DK0831938T3 (da) 1995-06-07 1996-06-06 Radiomærkede peptidsammensætninger til stedspecifik målsögninger

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK07019899.9T DK1872800T3 (da) 1995-06-07 1996-06-06 Radiomærkede peptidsammensætninger til stedsspecifik målsøgning

Country Status (10)

Country Link
US (2) US5830431A (pt)
EP (2) EP0831938B1 (pt)
JP (2) JP4236282B2 (pt)
AT (1) ATE395938T1 (pt)
CA (1) CA2224153C (pt)
DE (1) DE69637535D1 (pt)
DK (2) DK1872800T3 (pt)
ES (2) ES2395961T3 (pt)
PT (1) PT831938E (pt)
WO (1) WO1996040291A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
MY133346A (en) 1999-03-01 2007-11-30 Biogen Inc Kit for radiolabeling ligands with yttrium-90
US20020102208A1 (en) 1999-03-01 2002-08-01 Paul Chinn Radiolabeling kit and binding assay
US6358491B1 (en) 1999-08-27 2002-03-19 Berlex Laboratories, Inc. Somatostatin analogs
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
CA2410906C (en) * 2000-06-02 2012-10-02 Board Of Regents, The University Of Texas System Ethylenedicysteine (ec)-drug conjugates
CA2444483A1 (en) * 2001-04-26 2002-11-07 Board Of Regents, The University Of Texas System Diagnostic imaging compositions, their methods of synthesis and use
US7261875B2 (en) * 2001-12-21 2007-08-28 Board Of Regents, The University Of Texas System Dendritic poly (amino acid) carriers and methods of use
EP2316493A3 (en) * 2002-11-07 2011-08-10 Board of Regents, The University of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
WO2004081031A2 (en) * 2003-03-10 2004-09-23 Biogen Idec Inc. Thiol-mediated drug attachment to targeting peptides
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
EP1861127A1 (en) * 2005-03-10 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Chelators for radioactively labeled conjugates comprising a stabilizing sidechain
US8758723B2 (en) * 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) * 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
WO2011075678A1 (en) 2009-12-18 2011-06-23 The Board Of Trustees Of The Leland Stanford Junior University Specific inhibitors and active site probes for legumain
EP2889295A1 (en) 2010-08-12 2015-07-01 New York University Oligooxopiperazines and methods of making and using them
US9255086B2 (en) 2012-02-16 2016-02-09 New York University Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics
CN104768573B (zh) * 2012-05-08 2017-08-29 Trt创新有限责任公司 用于位点特异性uPAR靶向的177‑Lu标记肽
MX2017016863A (es) 2015-06-25 2018-09-06 Advanced Accelerator Applications Metodo de tratamiento de tumores neuroendocrinos que sobreexpresan receptores de somatostatatina.
ES2960030T3 (es) 2017-01-12 2024-02-29 Radiomedix Inc Tratamiento de células cancerosas que sobreexpresan receptores de somatostatina utilizando derivados de ocreótido quelados con radioisótopos
US10596278B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
US10596276B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
WO2020056064A1 (en) 2018-09-11 2020-03-19 Stanley Satz Tumor targeted radionuclide therapy and molecular imaging of her2+ cancers and other neoplasms, and precision medicine.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19375086I2 (de) * 1979-11-27 2003-01-09 Novartis Ag Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone
US4440904A (en) * 1983-01-31 1984-04-03 American Home Products Corporation Nonapeptide anti-secretory agents
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
JPH04236282A (ja) * 1991-01-18 1992-08-25 Aica Kogyo Co Ltd 接着剤組成物
EP0600992B1 (en) * 1991-08-29 2000-09-20 Mallinckrodt Medical, Inc. Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
US5411943A (en) * 1992-02-25 1995-05-02 Biomeasure, Inc. Hepatoma treatment with somatostatin analogs
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
CA2113121A1 (en) * 1993-01-12 1994-07-13 Rainer Albert Peptides
KR100325972B1 (ko) * 1993-08-09 2002-07-27 바이오메져 인코퍼레이티드 치료성펩타이드유도체
DE69434810T2 (de) * 1993-11-16 2007-08-02 Bracco International B.V. Immobilisiertes markierungsverfahren
EP0738158B1 (en) * 1994-01-12 2002-04-03 Amersham plc Biological targeting agents
EP0835662B1 (en) * 1996-10-08 2001-11-14 National Institute of Immunology A drug for the treatment of cancer

Also Published As

Publication number Publication date
ES2308778T3 (es) 2008-12-01
EP1872800A3 (en) 2008-03-19
JPH11507342A (ja) 1999-06-29
CA2224153A1 (en) 1996-12-19
CA2224153C (en) 2010-08-17
DK1872800T3 (da) 2013-02-04
DE69637535D1 (de) 2008-07-03
ATE395938T1 (de) 2008-06-15
EP1872800B1 (en) 2012-10-17
ES2395961T3 (es) 2013-02-18
PT831938E (pt) 2008-08-26
EP0831938A4 (en) 2001-12-05
US5804157A (en) 1998-09-08
JP4236282B2 (ja) 2009-03-11
EP1872800A2 (en) 2008-01-02
WO1996040291A1 (en) 1996-12-19
EP0831938B1 (en) 2008-05-21
EP0831938A1 (en) 1998-04-01
US5830431A (en) 1998-11-03
JP2008266342A (ja) 2008-11-06

Similar Documents

Publication Publication Date Title
DK0831938T3 (da) Radiomærkede peptidsammensætninger til stedspecifik målsögninger
Gregory et al. The primary structure of human urogastrone
IL141021A (en) Use of copolymer-like polypeptide-1 to prepare a drug to treat autoimmune diseases
ATE314097T1 (de) Kontrastmittel
BG103522A (en) Compositions and methods for ob type protein syntheses
ATE113063T1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
DK0762901T3 (da) Technetium-99m-mærkede peptider til imagografi
WO1998018497A3 (en) Contrast agents
DE69630708D1 (de) An den erythropoietin-rezeptor bindende zusammensetzungen und peptide
WO2000005249A3 (en) Synthetic peptides and methods of use for autoimmune disease therapies
ATE321774T1 (de) An aminosaeure angereicherte speicherproteine, insbesondere an lysin angereicherte mais-gamma- zeine, und diese exprimierende pflanzen
CA2303395A1 (en) Treatment of obesity
CA2439598C (en) Modified derivatives of cck-8
EP1279677A4 (en) GD3 MIMETIC PEPTIDES
WO2000073326A3 (en) Redox-stable, non-phosphorylated cyclic peptide inhibitors of sh2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
PT1095143E (pt) Inibidor para o diagnóstico e tratamento de doentes com hemofilia a
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
DK0811068T3 (da) Humane DNase I varianter
Pinas et al. Synthesis and biological properties of the [5-(N5-dimethyl)-glutamine]-analogue of the C-terminal heptapeptide of substance p: Active-site studies
Lee et al. Solid-phase edman degradation: A new method for attaching peptides to insoluble resins using trifluoroacetic anhydride
WO2003092744A3 (en) Benzothienyl analogue of somatostatin, selective for certain somatostatin receptors
ATE276273T1 (de) Vip-analoge
MX9706429A (es) Variantes de dnasa i humana.